An analysis of cardiac arrest records in a U.S. registry revealed that people with drug overdose cardiac arrests were more likely to be younger, have fewer health conditions and have higher survival ...

Scientists have created a three-dimensional "heart-on-a-chip" (HOC) that could provide a breakthrough in the fight against the world's leading cause of death, cardiovascular disease. One major ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

Cytokinetics, Incorporated CYTK announced that the European Commission (EC) has approved Myqorzo (aficamten), 5 mg, 10 mg, 15 ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

As the death toll mounts among patients taking cardiac medications in Pakistan, government officials there have taken steps to stem the fatalities. Details coming out of Lahore, a metropolis at the ...